Tag: science
-
Developing Gene Therapy Capacity in Thailand: Clinical, Economic, and Regulatory Perspectives
Kitipong Uaesoontrachoon1, Parin Rattananon1, Usanarat Anurathapan1,2, Suradej Hongeng11Genepeutic Bio, Co. Ltd., Bangkok, Thailand2Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand Abstract Gene therapy has emerged as a transformative therapeutic modality for genetic and hematologic diseases. In Thailand, where hemoglobinopathies and pediatric acute lymphoblastic leukemia (ALL) represent significant public health burdens, the development of domestic…
-
Artificial Intelligence in Cell Therapy: Advancing Development, Manufacturing, and Clinical Translation
Yu-Xiu Lin, M.Sc & Thai-Yen Ling, Ph.D.Graduate Institute of Pharmacology, College of Medicine, National Taiwan University, Taiwan Artificial intelligence (AI) is reshaping the life sciences industry at an unprecedented pace. Among the most transformative areas is cell and gene therapy (CGT), a field that promises curative approaches for cancer, genetic disorders, autoimmune diseases, and degenerative…
-
Beyond Carcinogenesis: Connecting Nicotine Signaling with Cancer Stemness and Metastatic Progression in Triple-Negative Breast Cancer
Yung-Che Kuo, Ph.D. 1 & Yen-Hua Huang, Ph.D. 1,2,31 TMU Research Center for Cell Therapy and Regeneration Medicine, Taipei Medical University, Taipei, Taiwan.2 Department of Biochemistry and Molecular Cell Biology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan3 International Ph.D. Program in Cell Therapy and Regenerative Medicine, College of Medicine, Taipei Medical…
-
Regulation of Cell and Gene Therapy (CGT) in Indonesia: Perspective of BPOM
D. Renovaldi, M.ScInternational Ph.D Program in Medicine, Taipei Medical University Introduction Cell and Gene Therapy (CGT) represents a rapidly advancing field in biomedical science, offering innovative treatment strategies for diseases that were previously difficult or impossible to treat. These therapies involve the modification or administration of living cells or genetic material to restore normal biological…
-
Indonesia Cell & Gene Therapy (CGT) 2026 Update
Josephine Diony Nanda, M.D., Ph.D.Department of Parasitology, Faculty of Medicine, Public Health, & Nursing (FKKMK), Universitas Gadjah Mada Cell and gene therapy (CGT) has emerged as one of the most transformative innovations in modern medicine, offering new hope for patients with previously untreatable conditions. In Indonesia, the journey of CGT is still in its early…
-
The New Era of Regenerative Medicine: Synergistic Development of Innovative Therapies and the National Health Insurance System
Lian-Yu Chen, M.D.,Ph.D.Director-GeneralNational Health Insurance Administration, Taiwan With the rapid development of regenerative medicine, innovative therapies are gradually transforming disease treatment paradigms. To address high-cost therapies associated with significant uncertainty, Taiwan’s National Health Insurance (NHI) has established corresponding reimbursement and management mechanisms. Cell and Gene Therapy: Opening a New Era of Medicine In recent years,…
-
Update on regulation of regenerative medicine in Taiwan – The management of the regenerative medicinal products act
Yueh-Tung Tsai, Wen-Hsiu Chiu, Chia-ping Liu, & Chih-Kang ChiangTaiwan Food and Drug AdministrationMinistry of Health and Welfare, Taiwan Corresponding Email: yttsai@fda.gov.tw; wenhsiu@fda.gov.tw; meat0901@fda.gov.tw; ckchiangtfda@fda.gov.tw Abstract Due to rapid development of biotechnology in recent years, the field of regenerative medicine has attracted considerable attention. On June 4th 2024, the Taiwan Legislative Yuan passed the“Regenerative Medicine Act”…
-
Ushering in a new regulatory era for regenerative medicine in Taiwan
Dr. Chih-Kang Chiang, MD., Ph.D.Director-GeneralTaiwan Food and Drug AdministrationMinistry of Health and WelfareTaiwan Due to rapid development of biotechnology in recent years, the field of regenerative medicine has attracted considerable attention. Regenerative medicine related regulations have been established in several countries to ensure the quality, safety and efficacy of innovative treatments. Considering the diversity of…
-
From Policy Blueprint to Implementation: The Current Status and Future Outlook of Regenerative Medicine in Taiwan
Yueh-Ping LiuDepartment of Medical Affairs,Ministry of Health and Welfare, Taiwan To respond to the rapid advancement of frontier medical technologies and the public’s growing expectations for more comprehensive healthcare options, the Ministry of Health and Welfare (MOHW) has long been committed to establishing a transparent and data‑driven governance framework for emerging medical technologies. The public…
-
Preface 2025 ACTO Annual Congress in Singapore
It is with immense pleasure that I welcome all invited speakers, delegates and honoured guests to the 2025 Asian Cellular Therapy Organisation (ACTO) congress held in Singapore. This congress is happening at a pivotal moment in the fast-evolving field of cell and gene therapy. There are bewilderingly rapid developments in diverse areas from approved gene therapy…
THE ACTO TIMES 